Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsShortsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Robert Andtbacka, MD, CM

Advertisement

Articles by Robert Andtbacka, MD, CM

Robert Andtbacka on Wound Care and Handling Drains After Melanoma Surgery

ByRobert Andtbacka, MD, CM
February 24th 2017

Dr. Robert Andtbacka explains the important role the nurse plays before and after surgery for melanoma.

Advertisement

Latest Updated Articles

  • Robert Andtbacka on Wound Care and Handling Drains After Melanoma Surgery
    Robert Andtbacka on Wound Care and Handling Drains After Melanoma Surgery

    February 24th 2017



Advertisement
Advertisement

Trending on Oncology Nursing News

1

Managing Rash and Stomatitis With Daraxonrasib in Pancreatic Cancer

2

FDA Approves Oral Nilotinib Tablets for Ph+ CML

3

Nursing Guide to Managing Lorlatinib in ALK+ NSCLC: 7-Year CROWN Insights

4

GLP-1 RAs Linked to Lower HR+ Breast Cancer Risk and Improved Survival

5

Pembrolizumab Improves 7-Year OS in Early-Stage TNBC: KEYNOTE-522 Final Data

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us